Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 937549, 11 pages
http://dx.doi.org/10.1155/2013/937549
Research Article

The Effect of Chinese Herbal Medicine on Albuminuria Levels in Patients with Diabetic Nephropathy: A Systematic Review and Meta-Analysis

1Department of Traditional Chinese Medicine, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China
2School of Traditional Chinese Medicine, Southern Medical University, Guangzhou, Guangdong 510515, China
3Endocrinology Department, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, China

Received 5 May 2013; Accepted 14 July 2013

Academic Editor: Francis B. Lewu

Copyright © 2013 Ya Xiao et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Ritz, I. Rychlik, F. Locatelli, and S. Halimi, “End-stage renal failure in type 2 diabetes: a medical catastrophe of worldwide dimensions,” American Journal of Kidney Diseases, vol. 34, no. 5, pp. 795–808, 1999. View at Google Scholar · View at Scopus
  2. L. J. Ubink-Veltmaat, H. J. G. Bilo, and B. Meyboom-de Jong, “Microalbuminuria in patients with type 2 diabetes mellitus in the general practice,” Nederlands Tijdschrift voor Geneeskunde, vol. 148, no. 41, pp. 2026–2030, 2004. View at Google Scholar · View at Scopus
  3. R. S. Scheffel, D. Bortolanza, C. S. Weber et al., “Prevalence of micro and macroangiopatic chronic complications and their risk factors in the care of out patients with type 2 diabetes mellitus,” Revista da Associacao Medica Brasileira, vol. 50, no. 3, pp. 263–267, 2004. View at Google Scholar · View at Scopus
  4. A. Y. T. Wu, N. C. T. Kong, F. A. de Leon et al., “An alarmingly high prevalence of diabetic nephropathy in Asian type 2 diabetic patients: the MicroAlbuminuria Prevalence (MAP) study,” Diabetologia, vol. 48, no. 1, pp. 17–26, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. F. C. Sasso, P. Chiodini, O. Carbonara et al., “High cardiovascular risk in patients with type 2 diabetic nephropathy: the predictive role of albuminuria and glomerular filtration rate. The NID-2 Prospective Cohort study,” Nephrology Dialysis Transplantation, vol. 27, no. 6, pp. 2269–2274, 2012. View at Google Scholar
  6. M. Gall, “Albuminuria in non-insulin-dependent diabetes mellitus: prevalence, causes, and consequences,” Danish Medical Bulletin, vol. 44, no. 5, pp. 465–485, 1997. View at Google Scholar · View at Scopus
  7. R. Z. W. Ting, A. O. Y. Luk, J. C. N. Chan et al., “Treatment and landmark clinical trials for renoprotection,” Contributions to Nephrology, vol. 170, pp. 184–195, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. KDOQI, “KDOQI clinical practice guidelines and clinical practice recommendations for diabetes and chronic kidney disease,” American Journal of Kidney Diseases, vol. 49, supplement 2, no. 2, pp. S12–S154, 2007. View at Google Scholar
  9. A. Luk and J. C. N. Chan, “Diabetic nephropathy—what are the unmet needs?” Diabetes Research and Clinical Practice, vol. 82, supplement 1, pp. S15–S20, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. L. Lai, J. Q. Hu, and X. F. Guo, “Evidence-based medicine and clinical studies of traditional Chinese medicine,” Journal of Guangzhou University of Chinese Medicine, vol. 17, no. 2, pp. 1–8, 2000. View at Google Scholar
  11. J. Lu and H. He, “Clinical observation of Gingko biloba extract injection in treating early diabetic nephropathy,” Chinese Journal of Integrative Medicine, vol. 11, no. 3, pp. 226–228, 2005. View at Google Scholar · View at Scopus
  12. S. T. Ma, D. L. Liu, R. Niu et al., “Double-blind, randomized, placebo-controlled multi-centre phase: clinical trial of Arctiin granule in the treatment of diabetic nephropathy,” The Chinese Journal of Clinical Pharmacology, vol. 27, no. 1, pp. 15–18, 2011. View at Google Scholar
  13. W. Y. Chen, “Clinical observation on Anshen yin treating 40 patients with diabetic nephropathy,” Guiding Journal of the Traditional Chinese Medicine Pharmacy, vol. 16, no. 3, pp. 26–28, 2010. View at Google Scholar
  14. Y. Xu, “Effect of treatment with Baoshen tang in patients with early stage diabetic nephropathy,” Liaoning Journal of the Traditional Chinese Medicine, vol. 32, no. 3, p. 213, 2005. View at Google Scholar
  15. H. Y. Luo, “Clinical research of Bushen Huoxue prescription in the treatment of early stage diabetic nephropathy,” Sciences, Technology and Engineering, vol. 8, no. 8, pp. 2176–2179, 2008. View at Google Scholar
  16. Y. Q. Huang and Y. S. Xu, “Clinical observation on Bushen Huoxue Tongluo fang treating 38 patients with early stage diabetic nephropathy,” Journal of the Traditional Chinese Medicine, vol. 49, no. 5, pp. 421–423, 2008. View at Google Scholar
  17. Y. C. Ge, H. L. Xe, S. J. Li et al., “Effect of tripterygium wilfordii in patients with diabetic nephropathy: a prospective randomized control clinical trial,” Nephrology Dialysis Transplantation, vol. 19, no. 6, pp. 501–507, 2010. View at Google Scholar
  18. J. Xue and J. W. Bai, “Effect of treatment with Liuwei Dihuang tang in 36 patients with early stage diabetic nephropathy,” Journal of Practical Traditional Chinese Internal Medicine, vol. 22, no. 2, p. 31, 2008. View at Google Scholar
  19. H. Q. Zhang, “Clinical observation on Pishen Shuangbu fang treating 38 patients with diabetic nephropathy,” Guiding Journal of the Traditional Chinese Medicine Pharmacy, vol. 18, no. 2, pp. 38–40, 2012. View at Google Scholar
  20. S. R. Huang, “Clinical research of Shen an prescription in the treatment of early stage diabetic nephropathy,” Journal of Changchun University of Traditional Chinese Medicine, vol. 27, no. 3, pp. 370–371, 2011. View at Google Scholar
  21. D. H. Zhang, K. F. Wang, and L. X. Yang, “Clinical observation on Tangshen kang capsule treating 113 patients with diabetic nephropathy,” Chinese Journal of Information on Traditional Chinese Medicine, vol. 18, no. 7, pp. 77–78, 2011. View at Google Scholar
  22. S. R. Huang, “Clinical research of Wenshen Jianpi Huoxue tang in the treatment of diabetic nephropathy,” Journal of Liaoning Universtity of Traditional Chinese Medicine, vol. 14, no. 1, pp. 159–160, 2012. View at Google Scholar
  23. Y. M. Dong, H. L. Li, and Q. Ni, “Clinical observation on Yiqi Huoxue fang treating 34 patients with early stage diabetic nephropathy,” Journal of the New Chinese Medicine, vol. 39, no. 6, pp. 76–78, 2007. View at Google Scholar
  24. H. Zhou, X. Z. Shang, P. F. Xie et al., “Clinical research of Yiqi Yangyin Jiedu Tongluo tang in the treatment of early stage diabetic nephropathy,” Tianjin Journal of Traditional Chinese Medicine, vol. 26, no. 2, pp. 100–102, 2009. View at Google Scholar
  25. F. L. Wang, Z. Q. Chen, Y. H. Wang et al., “Clinical research of Yiqi Yangyin Xiaozheng Tongluo tang in the treatment of early stage diabetic nephropathy,” Chinese Journal of Integrated Traditional and Western Medicine, no. 1, pp. 35–38, 2012. View at Google Scholar
  26. L. N. Zhong, Y. Shen, W. Guan, and F. F. Kong, “Clinical observation on Ziyin Zhuyang Digui tang treating diabetic nephropathy in 50 patients with deficiency of kidney yin and yang syndrome,” Beijing Journal of Traditional Chinese Medicine, vol. 31, no. 3, pp. 354–357, 2012. View at Google Scholar
  27. Y. B. Chen and Y. F. Wan, “Effect of treatment with Qishen Yiqi drop pill in patients with type 2 early stage diabetic nephropathy,” Chinese Journal of General Practice, vol. 14, no. 2, pp. 520–522, 2011. View at Google Scholar
  28. J. Wei, C. H. Fang, D. Y. Peng, Y. Chen, J. F. Zhu, and X. K. Gao, “Clinical observation on Fufang Danpi decoction treating diabetic nephropathy in patients with deficiency of qi and yin syndrome,” China Pharmacy, vol. 21, no. 3, pp. 255–257, 2010. View at Google Scholar
  29. T. B. Feng, G. Y. Chen, and G. Q. Xie, “Clinical research of Kangshen tang in the treatment of early stage diabetic nephropathy,” Hubei Journal of Traditional Chinese Medicine, vol. 27, no. 9, pp. 17–19, 2005. View at Google Scholar
  30. X. L. Zhu, W. F. Xu, and M. H. Ye, “Effect of treatment with Pingxiao Gujing tang in 22 patients with early stage diabetic nephropathy,” Chinese Journal of Integrated Traditional and Western Nephrology, vol. 5, no. 3, pp. 156–157, 2004. View at Google Scholar
  31. J. Li, X. He, and Q. Li, “Clinical study on treatment of early diabetic nephropathy by tangshenling combined with telmisartan,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 26, no. 5, pp. 415–418, 2006. View at Google Scholar · View at Scopus
  32. M. L. Pan and F. M. Xue, “Effect of treatment with Tangshen tang in patients with early stage diabetic nephropathy,” Beijing Journal of Traditional Chinese Medicine, vol. 28, no. 4, pp. 289–290, 2009. View at Google Scholar
  33. J. S. Gong and H. T. Wang, “Clinical research of Yangyin Yiqi decoction in the treatment of early stage diabetic nephropathy,” Research Information of the Traditional Chinese Medicine, vol. 6, no. 8, pp. 18–19, 2004. View at Google Scholar
  34. W. Cai, Q. Lv, and D. Han, “Effect of Yiqi Yangyin Huazhuo Tongluo recipe on plasma CTGF, type IV collagen and Cys C in patients with early stage diabetic nephropathy,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 18, no. 14, pp. 266–268, 2012. View at Google Scholar
  35. Z. G. Qu, “Effect of treatment with integrated traditional and western medicine in 36 patients with diabetic nephropathy,” TCM Research, vol. 25, no. 7, pp. 19–21, 2012. View at Google Scholar
  36. B. Li, “Summarization on the combination of Chinese medicine and western medicine for the treatment of 20 cases of early stage diabetic nephropathy,” Hunan Guiding Journal of the TCM, vol. 10, no. 7, pp. 16–17, 2004. View at Google Scholar
  37. G. H. Wu and X. P. Zhang, “Effect of treatment with Integrated traditional and western medicine in 30 patients with early stage diabetic nephropathy,” Guiding Journal of the TCM, vol. 11, no. 5, pp. 23–24, 2005. View at Google Scholar
  38. X. Q. Chen and Y. P. Huang, “Clinical study on treatment of early diabetic nephropathy by self-composed Wuchong tang combined with Lotensin,” Traditional Chinese Medicine Journal, vol. 5, no. 4, pp. 47–49, 2006. View at Google Scholar
  39. M. K. Fallahzadeh, B. Dormanesh, M. M. Sagheb et al., “Effect of addition of silymarin to renin-angiotensin system inhibitors on proteinuria in type 2 diabetic patients with overt nephropathy: a randomized, double-blind, placebo-controlled trial,” American Journal of Kidney Diseases, vol. 60, no. 6, pp. 896–903, 2012. View at Google Scholar
  40. P. Khajehdehi, M. Pakfetrat, K. Javidnia et al., “Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study,” Scandinavian Journal of Urology and Nephrology, vol. 45, no. 5, pp. 365–370, 2011. View at Publisher · View at Google Scholar · View at Scopus
  41. A. R. Jadad, R. A. Moore, D. Carroll et al., “Assessing the quality of reports of randomized clinical trials: is blinding necessary?” Controlled Clinical Trials, vol. 17, no. 1, pp. 1–12, 1996. View at Publisher · View at Google Scholar · View at Scopus
  42. X. P. Liu and J. P. Li, “Studies on pathologic evolution law of diabetes nephropathy,” Chinese Journal of Chinese Medicine, vol. 4, no. 3, pp. 672–673, 2010. View at Google Scholar
  43. J. F. Navarro-González, C. Mora-Fernández, M. M. De Fuentes, and J. García-Pérez, “Inflammatory molecules and pathways in the pathogenesis of diabetic nephropathy,” Nature Reviews Nephrology, vol. 7, no. 6, pp. 327–340, 2011. View at Publisher · View at Google Scholar · View at Scopus
  44. D. K. Singh, P. Winocour, and K. Farrington, “Oxidative stress in early diabetic nephropathy: fueling the fire,” Nature Reviews Endocrinology, vol. 7, no. 3, pp. 176–184, 2011. View at Publisher · View at Google Scholar · View at Scopus
  45. X. Zhou, B. Wang, L. Zhu, and S. Hao, “A novel improved therapy strategy for diabetic nephropathy: targeting AGEs,” Organogenesis, vol. 8, no. 1, pp. 18–21, 2012. View at Google Scholar
  46. Y. Zhang, C. Wu, and J. Cheng, “Merit of astragalus polysaccharide in the improvement of early diabetic nephropathy with an effect on mRNA expressions of NF-κB and IκB in renal cortex of streptozotoxin-induced diabetic rats,” Journal of Ethnopharmacology, vol. 114, no. 3, pp. 387–392, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. X. Yin, Y. Zhang, J. Yu et al., “The antioxidative effects of astragalus saponin I protect against development of early diabetic nephropathy,” Journal of Pharmacological Sciences, vol. 101, no. 2, pp. 166–173, 2006. View at Publisher · View at Google Scholar · View at Scopus
  48. S. Lee, Y. Kim, S. Lee, and B. Lee, “The protective effect of Salvia miltiorrhiza in an animal model of early experimentally induced diabetic nephropathy,” Journal of Ethnopharmacology, vol. 137, no. 3, pp. 1409–1414, 2011. View at Publisher · View at Google Scholar · View at Scopus
  49. D. Gao, Q. Li, Z. Gao, and L. Wang, “Antidiabetic effects of Corni fructus extract in streptozotocin-induced diabetic rats,” Yonsei Medical Journal, vol. 53, no. 4, pp. 691–700, 2012. View at Google Scholar
  50. K. F. Schulz, D. G. Altman, and D. Moher, “CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials,” Journal of Pharmacology and Pharmacotherapeutics, vol. 1, no. 2, pp. 100–107, 2010. View at Google Scholar